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Could you prevent the death of a person poisoned with a 
cholinesterase inhibiting agent? If you can answer this yes, then 
I ask you if you could successfully treat several patients at once 
with this poisoning? Our society in the near future may place this 
challenge upon you. 
Maybe you answered "No" to both the above questions and ask, 
It¥<)hat is a cholinesterase-inhibiting agent?" 
In 1939 a German scientist by the name of Schrader was search-
ing for a more effective insecticide and discovered "Nerve Gas", a 
cholinesterase-inhibiting agent. Since this discovery, .many re-
finements have been made on this agent and now it can be used as the 
base for excellent insecticides and has potential use as a "war gaslt 
against man. 
My purpose in this paper is to present SOIOO of its military po-
tential, medical uses, mode of action, present concepts in treatment, 
and some of the unusual problems that may present themselves to med-
ical personrlel in the event that this agent is used against large 
populations, either rrilitary or civilian. 
World i7a.r I proved the effectiveness of chemical warfare. A 
difficult lesson learned must not be forgotten quickly. This lesson 
was given in April 1915 by the Germsns Vllhen they released chlorine 
gas against the Allies in France. The effect of this type of vmrfare 
was profound and demoralizing, and the casualties were many. 
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The Germans developed a compound YJlOYIITI as Tabun, a nerve gas 
and cholinesterase-inhibitive agent in World War II. At the close 
of the war a large C~rn~n plant for the manufacture of Tabun was 
captured by the Russians and rreved back to Russia. So we know that 
other countries can manufacture these agents. 
Since World War I gas warfare has not been used, either because 
of International Rules of Warfare or the fear that the opponent may 
retaliate in kind if used a gainst him. However, nuclear weapons 
with their vast devastating powers have been used in the past and 
are in future plans in certain cases. Therefore if these awesome 
weapons are under consideration for use, one must assume that chem-
ical agents are under consideration for use. 
Some of the reasons that cholinesterase-inhibiting agents may 
be used in future warfare are the following: 
1. Not all countries in the world can afford financially to 
develop nuclear weapons, nor do they have the sc:i.entists 
to develop and perfect them. 
2. Cholinesterase-inhibiting agents are easy to produce and 
there is an abundance of raw material. Any major military 
p~~er could produce hundreds of tons of this agent per day. 
3. Therefore it is possible that a small nation without nu-
clear weapons could wage war just as effectively in terms 
of death to the enemy, using cholinesterase-inhibiting a-




Recently L. J. LeRoux, vice president of the National Council 
for Scientific and Industrial Research, stated that South African 
scientists are working on "deadly gases" as a low cost military 
weapon that can cause massive devastation comparable to that from 
nuclear weapons. Cholinesterase-inhibiting agents also have these 
advantages: 
1. 'Ibey could be used in a way that identification of the ag-
gressor would be impossible. 
2. These agents are colorless, odorless and cause no irrita-
tion to the body that give warning of exposure until the 
patient has been seriously poisoned. Therefore identifica-
tion of the agent or the attack may be too late. 
3. Saboteurs could spread these agents against large cities or 
military bases with little chance of being detected. 
4. These agents are at least twice as lethal as any previous-
ly known chemical agent. In fact one deep breath or a few 
droplets of this agent on skin may result in death. The 
time between exposure and death may be seconds. 
5. It is conceivable that these agents can be delivered by 
aircraft or long range missiles. 
6. These agents do not destroy property and once the area has 
been decontaminated, either through human efforts or natures 
method of time and weather, the area may be occupied and 
its industry utilized. 
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The above introduction gives only a few of the reasons why 
this type of poisoning may be seen in the mass casualty situation 
in the future. 
If you still aren't convinced that this type of poisoning 
may be a common one in the future and justifies your knowing how to 
treat this poisoning, then let us proceed to its use as an insecti-
cide. The cholinesterase-inhibitor agents constitute the base of 
many of the commercial insecticides today. Certainly the insecti-
cides aren't as lethal in small concentrations as the "war gases", 
but workers spraying fields can easily become dangerouslY conta~ 
inated with large doses of them. Contamination can take place 
either by inhalation, through the skin, or by ingestion. The know-
ledge of the possible routes of poisoning can lead the imagination 
to supply thousands of possible ways that people handling insecti-
cides could accidently be poisoned. 
Cholinesterase-inhibiting agents are also used medically in the 
treatment of glaucoma, myasthenia gravis, and abdominal distention. 
Therefore prescribing or ingesting toxic doses in the treatment of 
the above medical problems could also lead to the same type poisoning. 
FUNCTIONS OF ACETYLCHOLINE 
The name of the type of poisoning suggests its action. Cholines-
tera.a-inhibiting agents act as an irreversible inhibitor of the en-
zyme cholinesterase, allowing accumulation of large amounts of acetyl-
4 
choline. "Therefore one may look at the poisoning as an excess of 
acetylcholine. '1.bat is acetylcholine? ~at is it's physiologic 
function? 
Acetylcholine is a methylated quarternary ammonium saL t found 
at nerve terminals in the neuromuscular motor end plate, at all auto-
nomic preganglionic fibers, all parasympathetic postganglionic fibers 
and the sympathetic postganglionic fibers supplying sweat glands. 
Nerves that liberate an acetylcholine like transmitter are called 
cholinergic fibers. 
The nerve terminal contains many vesicles which are microscopic 
packets containing a constant number of acetylcholine molecules, 
roughly 1,000 to 10,000. An impulse traveling dam a nerve fiber 
depolarizes the nerve terminal and releases the acetylcholine. The 
acetylcholine then diffuses across the small gap between the nerve 
ending and the ootor end plate. The end plate has an acetylcholine 
receptor complex Which increases the permeability of the end plate 
membrane to all ions. This leads to end plate depolarization. When 
the depolarization hits threshold levels an impulse is generated and 
the muscle contracts or the nerve impulse is transmitted on in the 
case of the ganglion fibers listed above that respond to acetylcholine. 
In summary acetylcholine is a chemical mediator necessary for the 
transmission of the nervous impulse. 
FUNCTIONS OF CHOLINESTERASE 
AcetylcrJOline is hydrolyzed almost instantly so that the synapse 
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is ready to transmit a physiologic impulse. If acetylcholine is al-
lowed to accumulate there is an abnormal increase in function rang-
ing from muscle fasciculations to paralysis. To prevent the repeti-
tive firing of muscles, the acetylcholine is destroyed or actually 
hydrolyzed in a few milliseconds by an enzyme called acetylcholines-
terase to choline and acetate. 
This action can be represented by the following diagram from 
the Biochemistry text of Cantarow and Schepartz5: 
C ho/i,Jt sle rc IH-e tN'~ lM~ 
An anionic site and "esteratic tf site. The esteratic site is the 
site of fiydrolysis and the one to consider here. When the acetyl-
choline and the enzyme combine acylation of site X occurs and the 
acyl group is transferred from the enzyme to a water molecule. The 
substrate end products are choline and acetate. 
There are two general types of cholinesterase. The first is a 
true and very specific enzyme called acetylcholinesterase. In hu-
mans this is found in nervous tissue and in red blood cells, and has 
great functional importance in neurohumoral transmission in muscles 
6 
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and glands. 
The second type is a non-specific en~me called pseudocholines-
terase and is found in blood plasma. Pseudocholinesterase is re-
generated in the liver and therefore is closely related to liver 
function. It is known that when the level of pseudocholinesterase 
is lowered by any cause it takes approximately 120 days to regener-
ate fully; therefore this enzyme reflects the rate of red blood cell 
replacement. As far as it is known pseudocholinesterase does not 
have any function in neurohumoral transmission. It does, however, 
break down procaine and succinylcholine. 
MEASU~T OF CHOLINESTERA~ 
Much work has been done tryj.!ilg to find a suitable method of 
assaying cholinesterase levels. Temperature, pH of medium, salts 
and ionic strength of media influence the test. Most m.ethods of as-
saying cholinesterase are based on the determination of the rate of 
disappearance of acetylcholine or the rate of formation of acetic 
acid from the hydrolysis of acetylcholine. 
The most accurate and sensitive methods are the recording 
titrimetric and Warburg Manometric procedures in which the amount 
of acid is measured stoichiochemically. 
The method of Michel is an electro.metric method in which a 
change in pH is measured. This method is not as accurate as the 
aforementioned method, but it is suitable for assaying large numbers 
of samples. 
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.A field method has been tried, using whole blood and bromothymol 
blue as a test baaed on matching the color of glass standards against 
the color of reaction mixtures. So far this methcxl has been un-
satisfactory because of lack of suitable normal standards. 
Blood being sent away for analysis should be separated into 
cells and plasma. The samples should be refrigerated to 0 to 50 
centigrade. 
CHOLINESTERASE INHIBITORS 
The cholinesterase inhibitors are rapidly absorbed with con-
tact to the eyes, skin, respirator,y tract, gastrointestinal tract 
leading to systemic manifestations of the poisoning. 
Insecticides have a high acute toxicity but fortunately are not 
as toxic as the "war gases". So far the agriculture residues on 
food have not been a problem because the insecticides break down 
rapidly upon exposure to weathering. Animals whose food is con-
taminated with cholinesterase inhibiting agents do not store the 
agent in their bodies. The pharmacologic action of the cholinester-
ase inhibiting agents is that of inhibiting the enzyme cholinester-
ase. The excess acetylcholine that accumulates causes over-stimu-
lation of the parasympathetic nervous system. Excessive secretion 
by the glands they innervate occurs. The action of excessive 
acetylcholine at the myoneural junction can lead to curare like 
flaccid paralysis. Therefore the Cholinesterase-inhibiting agents 
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interfere with respiration by directly depressing the respiratory 
center, by paralyzing musoles of respiration, by causing exoessive 
respiratory secretion and finally bronchoconst.ric tion. Many authors 
st.at.e that. the bronohoconstriction observed in animals exposed to 
these agent.s does not occur in en. 
The level of cholinest.erase in both .man and animals can be 
gradually depressed without. signs or symptoms; thus the action of 
these agents depends on both the degree and the rate of depression. 
A point might be made that it takes approximately 90% cholinesterase 
inhibition at the respiratory centers to oause respiratory failure. 
Thus, considering treataent, even a slight degree of oholinesterase 
reactiveation at this oritioal site may relieve failure of respira-
tory movements. 
SIGNS AND SYMPTOMS 
The signs and symptoms of antioholinesterase poisonings may 
vary in severity, in rapidity of onset, in duration and in range, 
depending on the route and magnitude of exposure. Systemio poison-
ings lead to muscarine-like and nicotine-like effects. The nicotine-
like effects are usually not seen until muscarine effects have 




3 . Conjunctival hyperemia 
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4. Pressure sensation behind eye 
5. Headache 
6. Funnel vision 
7. Blurred vision 
Respirato£Y effects 
1- Increased respiratory tract secretions 
2. Rhinorrhea 
3. Nasal hyperemia 
4. Tightness in chest 
5. Wheezing 
6. Dyspnea 
7. Pulmonary edema ,- 8. Cyanosis 







5. Abdominal cramps 
6. Diarrhea 





2. Looal fasiculations 




1. Increased sweating 
Central Nervous System 
1. Tension 
2. Anxiety 
3. Emotional lability 
4. Insomnia 
5. Exoessive dreaming 




10. Grand mal seizures 
11. Coma 
12. Loss of reflexes 
Some authors believe that miosis is an early diagnostic sign, 
others feel that the "pin point" pupils should not be relied upon 
too much as an early sign. In general the "eye signs", rhinorrhea, 
increased respiratory secretion, tightness in chest, weakness, 
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sweating, abnormal cramps will be seen early or in less severe 
poisonings. Loss of reflexes, convulsions, coma, loss of sphincter 
control, such as involuntary defecation or urination are usually 
seen in advanced cases. 
LABORATORY FINDINGS 
Laboratory findings in anticholinesterase poisonings are de-
creased serum cholinesterase levels, lelL~ocytosis and albuminuria. 
Frequently acetonuria, glycosuria and hemoconcentration are seen. 
In the absence of symptoms there is no electroencephalogram (EEG) 
changes. EKG may demonstrate various A-V blocks ani bradycardia. 
The most reliable laboratory finding in making a diagnosis is the 
cholinesterase levels. The cholinesterase levels may be depressed 
considerably below normal before signs and symptoms appear. 
Grob15 states that he has found evidence of only depressed 
cholinesterase levels. Grob could not find any alterations in the 
chemical constituents or formed elements of the blood and no change 
in the urine or renal or hepatic function. 
PATHOLOGY 
The gross or microscopic pathologic findings are not signifi-
cant. Evidence of pulmonary or cerebral congestion or changes 
secondary to convulsions are often seen. 
MECHANISM OF DEli TH 
The mechanism of death is due to respiratory failure. The re-
spiratory failure is due to paralysis both centrally and peripherally. 
12 
___________________ ¥~~-w-____ .--~~----------__ =_ __ ._, ____ ¥¥WO __ ~ __________________ ~--~ ________ ----__ _ 
The peripheral paralysis is brought about by muscle fatigue and the 
curare-like blocking of the myoneural junctions of the diaphragm 
and accessory muscles of respiration. This leads to profound anoxia. 
The anoxia at first stimulates the chemoreceptors to try to increase 
respiratory rate and correct the anoxia. Continued anoxia rapidly 
depresses the respiratory center. 
Brown3 described an experiment which proves there is also a 
central respiratory failure due to cholinesterase inhibiting agents. 
This test was done with Itsarinlt , one of the war gases. Sarin was 
injected intravenously and before the respiratory- muscles were para.-
lyzed as evidenced by the twitch height of muscles, respirations 
ceased. This occured before anoxia or neuromuscular effects were 
demonstrated. The experimental animals were given a therapeutic 
injection of atropine and respiratory stimulant. The rapidity of 
respiratory failure after cholinesterase inhibiting agents were 
given and the equally rapid recovery after atropine injection sea~ed 
to leave little doubt about the central origin of respirator,r fail-
ure in addition to peripheral failure to paralysis. 
The profound anoxia and the increasing accumulation of acetyl-
choline in the nervous system leads to intermittent and then almost 
continuous grand mal seizures until flaccid paralysis supervenes. 
The anoxia and acetylcholine affect the cardiovascular system. 
The anoxia at first initiates hypertension but if the anoxia is not 
improved the blood pressure completely falls leading to circulatory 
13 
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collapse. A cholinergic effect of acetylcholine is bradycardia. 
TREATM8:NT 
Grob12 gives this method of treating anticholinesterase poison-
ings. These are not necessarily the preferred order of treatment. 
1. Remove from exposure 
2. Decontaminate 
3. Remove secretions 
4. Maintain adequate airway 
5. Apply artificial respiration if needed 
6. Administer atropine 
7. In severe cases a~~nister oximes (2-PAM) 
8. If convulsions present, treat with trimethadions (Tridione) 
The patient should be removed from exposure. This$ep is not 
important with poisonings due to ingestion but it is vitally im-
portant when dealing with the "war nerve gases lf or insecticides. 
If the patient is still absorbing poisons from the skin or lungs 
due to contamination of the environment he will become more toxic 
while you are treating him. 
Medical judgment is as important in treating anticholinesterase 
poisonings as any other acute medical emergency. Decontamination 
should begin as soon as possible, however, one should not direct 
all the attention t.p decontamination 'when respiration has ceased. 
There are some unusual situations that must be consj.dered here. 
Physicians must remember that these compounds are readily absorbed 
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throl.l.gh the skin and airways. Therefore attendants should remember 
to protect themselves from contamination. Non-military poisonings 
can probably be dealt with merely by wearing rubber gloves to pre-
vent skin contamination. Volatile compounds can contaminate the 
atmosphere making special individual protection such as gas masks 
and protective clothing necessary. 
Decontall1.ination of gastrointestinal tract should be carried 
out by prompt induction of emesis. Durham and Hayes article 9 
states that experiments have indicated that vomiting induced imme-
diately or even l~ hours after ingestion is more effective then 
gastric lavage in removing poison. Induce vomiting and then give 
some neutral material such as water or milk and induce the vomiting 
again. Vomiting should never be induced if the patient is uncon-
scious unless an endotrachial tube ia inserted beforehand. If the 
patient is unconscious, or the vomiting profuse, gastric lavage may 
be done with 5% sodium bicarbonate. 
All contaminated clothing must be rerr~ved as quickly as possible. 
Care must be taken to prevent contamination during the disposal of 
the clothes. The clothing should be buried rather than burned. 
Vapors released from burning contaminated materials could contsll1in-
ate the surrounding atmosphere. 
The patient should be washed with soap and lots of water. 
Care should be taken to avoid abrasion of the skin, for this would 




bathe ~th ethyl alcohol. ~ny insecticides and the oil based 
cholinesterase inhibitors are more soluble in alcohol than in water. 
The eyes absorb the anticholinesterase agents remarkedly rapid. 
If they are suspected of being contaminated, irrigate them with 
physiologic saline or tap water. 
The upper respiratory tract lihould be suctioned to re!IX)ve se-
cretions. Endotraoheal intubation should be done as soon as possi-
ble. Intubation helps maintain an adequate airway and it certainly 
helps aspirating the thick mucus which might prove to be very diffi-
cult with a rubber oatheter being passed alone down the trachea. A 
tracheostomy may be necessary but most authors agree that intubation 
is superior in that it can be done very rapidly, and the patient is 
not subjected to the hazards of tracheostomy. )Jost physicians a-
gree that, if an airway must be maintained over twenty-four to 
forty-eight hours, a tracheostomy should be done; but response to 
specific therapy of anticholinesterase poisoning is so rapid usually 
that tracheostomy is not needed. 
Artificial respiration must be given if respiration has either 
failed or is inadequate. A note of caution should be given on 
mouth-to-mouth respir'ation on a "nerve gas!! casualty. The adroin-
istrator could become a victim of the same lethal chemical agent. 
This author has not read any articles reporting poisordr~ to the 
adrdnist.rator of mouth-to-mouth respiration of an insectidde type 
of Cholinesterase-inhibiting agent. 
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A mechanical respirator with a non-rebreathing valve could be 
most ideal and one should be procured and maintained at the bedside 
even if the casualty does not need it immediately. The patient 
should be watched very closely for at least forty-eight hours for 
sudden respiratory arrest. Sudden respiratory arrests have been 
known to occur i..'1 the first forty-eight hours even though the patient 
appears to be responding well clinically. 
The administration of atropine is specific for anticholinester-
ase poisoning. The intravenous route is the preferred .rrethod of 
administration because the effects are seen within four minutes 
and are maxirr..al in eight minutes. Atropine should be given as soon 
as possible. 
Wills et a123 states that atropine must be given within one 
minute of severe exposure to sarin, a nerve gas, if treatment is to 
be effective. The reason for this is that death occurs very rapidly, 
usually within a few minutes after severe exposure to sarin. This 
author has not read any articles in the review of literature that 
gives a time limit to the effectiveness of atropine in insecticide 
poisoning of the anticholinesterase type. One ass~~es atropine 
will be beneficial if given at any time during the course anti-
cholinesterase poisonings, assur~g the patient lives long enough 
after adnli.n,istration for the pharmacologic action to occur. 
The point being, the atropine must be given within a few min-
17 
utes in severe poisoning in order to save the patients life but 
can also be very helpful in mild to moderate poisonings if given 
for the first time several hours after exposure. 
The antidote effect of atropine in anticholinesterase poison-
ings is not due to any action on, or neutralization of the anti-
cholinesterase compound. Atropine merely serves to block certain 
actions of the excess acetylcholine accumulated. Atropine speci-
fically blocks the muscarinic actions of acetylcholine such as 
glandular secretion, and slovdng of the heart. It is also specific 
to reverse the effects of anticholinesterases in the central ner-
vous system especially the central respirator,y center. Atropine 
has absolutely no effects on the nicotine-like effect of excess 
acetylcholine. These effects are increased fatigability, general-
ized weakness, involuntary muscular twitching, muscle cramps, 
fasciculations and muscular paralysis. 
Atropine will not prevent respiratory failure due to respira-
tory muscle paralysis nor will it restore strength to respiratory 
or pharangeal muscles. 
The symptoms of atropine if administered to a normal subject 
are dryness of mouth, pharynx, a slight difficulty in swallowing, 
dilated pupils, dry flushed skin, blurry near vision, subjective 
feeling of warmth, slight tachycardia, mild drowsiness, slowness 
of memory and occasionally hallucinations. 
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DOSAGE OF ATROPINE 
Most authors recoIn.!Ilend t'WO to four milligrams intravenous 
atropine to be given as soon as cyanosis is overcome. Atropine in 
doses of two milligrams given intravenously should be given at five 
to ten minute intervals until signs of over atropinization appear 
(see above symptoms of atropine) or until symptoms are relieved. 
Poisonings by anticholinesterase compounds increase the tolerance 
for atropine. A severely poisoned individual may take as many as 
forty milligrams or more before signs of over atropinization are 
produced. A mild degree of over atropinization should be maintained 
for twenty-four hours in a mild poisoning case, and forty-eight 
hours in a severe case. Over atropinization may be a little inca-
pacitating but presents little challenge to life. 
Atropine should not be administered for preventative purpose 
in persons who anticipate exposure to the "nerve gases" or contamin-
ation while working with various insect.icides. The reason for this 
is that this may mask early symptoms, increase respiratory absorp-
tion of the anticholinesterase by inhibiting bronchial secretion, 
and in general allowing the person to expose himself to higher 
levels of poisoning without warning. Atropine itself may render a 
person unfit for his occupation. 
CONTRAINDICATIONS FOR USE OF ATROPINE 
The use of atropine in anticholinesterase poisonings is contra-
indicated in one very important situation. This situation is the 
19 
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anoxic patient. Granted it has been pointed out that atropine must 
be given as soon as possible if death is to be prevented in serious 
cases. However if the patient is cyanotic or anoxic this condition 
~ be corrected by artificial respiration and oxygen first. It is 
known that atropine releases the heart from vagal control. The 
tachycardia that occurs leads to an increased work load on the car-
disc muscle. The increased strain on the heart in face of severe 
anoxia will often lead to immediate ventricular fibrillationrsnd 
death. 
0.5% atropine opthalmic solution may be locally applied to 
the eye to relieve the ocular symptoms produced by local absorption 
of anticholinesterase agents. Often systemic atropine does not 
relieve the miosis. 
There has been much investigation in the past few years into 
agents that would reactivate cholinesterase. The most success ap-
peared to be with the oximes. The most successful oxime appears 
to be 2-PAM chloride. This is 2-pyridine aldoxime methochloride. 
Its chemical structure is: 
The specific activity of 2-PAM rests in the 2-formyl-l-methyl-
20 
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pridinium ion and ~independent of the particular salt used. Chlo-
ride, iodide, methylsulfate and methane sulfonate salts have been 
used and tested. The chloride is preferred because of better water 
solubility at all temperature, a higher potency per gram and fewer 
side effects. 
2-PAM chloride is capable of reversing the combination between 
a cholinesterase molecule and the inhibitor causing reactivation of 
cholinesterase. 2-PAM chloride does not replace the need for atro-
pine in treatment of anticholinester~se poisonings because the 
oximes and atropines have different sites of action. It is prefer-
able to use these two agents in combination and take advantage of 
the antidotal effects of both at their different sites of action. 
It is thought 2-PAM potentiates the action of atropine, and in-
creases the signs of over atropinization. The mechanism of action 
for this may be due to 2-PAM reactivating the cholinesterase and re-
moves the accumulated actylcholine, leaving the large doses of 
atropine to give an unopposed drug effect. 
The mechanism of action of 2-PAM in regenerating the inhibited 
cholinesterase is thought to be due to direct combination with the 
phosphorus inhibited enzyme. 2-PAM aids or causes a reaction in 
which the phosphorus moiety is split off and hydrolyzed. 2-PAM 
residue appears to undergo a further reaction to regenerate the 
active enzyme. The important thing from a practical point is that 
2-PAM has a greater affinity for the phosphorus moiety than does 
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the enzyme. 
ROUTES OF ADMINISTRATION 
2-PAM can be administered intravenously, intramusculary, orally 
Subcutaneously and has some penetration to the cornea when applied 
topically. The preferred route is intravenous administration be-
cause it is immediately dispersed throughout the extra cellular 
water and gives a high plasma level. 
DOSAGE 
The usual adult dOlle is 1000 milligrams initially and this can 
be injected directly in the vein at a rate not to exceed 500 milli-
grams per minute. The dose may also be mixed in 250 cc of saline 
and given over a thirty minute period. Ii second dose of 1000 mil-
ligrams of 2-PAM can be given one hour after initial dose if mus-
cular weakness persists but caution should be used and facilities 
to maintain respiration should be in readiness for 2-PAM in high ex-
cessive doses is a weak anticholinesterase agent itself. 
The dose for children is 25 to 50 milligrams per kilogram. 
2-PAM is promptly and adequately absorbed orally. Marked drug 
effect is seen in thirty minutes and persists for approximately ten 
hours. The drug is probably not completely absorbed and some non 
excretory prooess are operated by this route so the dosages and 
dosage intervals are different in oral route. 
One to four grams may be given orally on initial dose depending 
on severity of poisonings. lti.ld cases usually show full remission 
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in one hour when one to two grams are given orally. This dose may 
be repeated after three hours i.f necessary. 
SIDE EFFECTS 
The side effects of 2-PAM on normal subjects are dizziness, 
blurred vision, diplopia, headache, impaired accomodation, nausea, 
slight transient tachycardia. There are no demonstrable changes on 
blood pressures, EKG, respiration, urinalysis, liver function tests, 
bleeding or clotting times. No irritation at site of extravasation 
on intramuscular injection. In general 2-PAM appears to feature a 
low toxicity. 
The time limit that 2-PAM must be administered after anticholin-
esterase poisoning, to be maximally effective is not known. It is 
felt that administration of 2-PAM thirty-six hours after exposure is 
not too beneficial. 
TREATMENT OF CONVULSIONS 
Patients with severe anticholinesterase poisonings may develop 
convulsions. If the convulsion interferes with artificial respira-
tion and oxygen therapy, treat with trimithadione, one gram intra-
venously every fifteen minutes until controlled. Barbituates or 
ether may be given. The action of succinylcholine increases the 
effect of anticholinesterase agents, thus the use of this relaxa~t 
is contraindicated. 
Care must be taken in administering barbituates, anticholines-




Morphine, theophylline, aminophylline, are strictly contraindi-
cated in these cases. Smoking should be forbidden as this increases 
the respiratory and gastrointestinal symptoms. 
Tranquilizers should be used with great caution. Som of the 
phenothiazine derived tranquilizers are suspected to potentiate cer-
tain anticholinesterase agents. 
PROGNOSIS 
If death does not intervene, recover,y from anticholinesterase 
poisonings is usually complete. However the cholinesterase level 
may remain low until regeneration restores normal level. Patients 
are very susceptible to even small exposures of anticholinesterase 
until this level is restored. This point should be seriously con-
sidered when further exposure is an occupational hazard. 
Miosis and headaches are often the only residual effect and 
this is a minor one compared to the seriousness of this type of 
poisoning. They usually respond well to topical application of 0.5% 
atropine to the eyes. 
MASS CASUALTIES 
If the cholinesterase-inhibiting agents are ever used as a "war 
gas" it would present many problems. Many of these problems are 
similar to those in all wars, some are new. 
The problems are to initiate treatment quickly, decontaminate, 
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have as few sites as possible giving treatment and thus reduce 
problems of supply, to keep from contaminating all of the medical 
station, get maximum use out of equipment, and finally to set up 
a system where the lowest number of medical personnel can maintain 
the largest possible number of casualties. 
Clinically the problem of separating the types of injury, de-
termining the seriousness of injury and routing the patient to 
properly equipped medical station to care for a given injury is a 
basic problem of triage. 
There oould be a high number of oasualties in a short period 
of time. These oasualties could be in different states of inca-
pacity. One of the first problems is to make a diagnosis of anti-
cholinesterase poisonings. Good military intelligenoe forewarning 
of attack is of great importance. A good rule may be to consider 
all attacks on the United states to inolude "nerve warfare" until 
proven otherwise. Certainly whenever the first proven case of 
anticholinesterase poisoning is found the information should be 
sent to all medical facilities in the area. A definite plan of 
communication should be made because speed is of utmost importance. 
A disaster plan covering nerve gas attacks should be initiated in 
suoh a way that administration and communication are given the 
highest consideration. Mass panic and confusion could be one of 
the greatest dangers to nerve gas attack. Well trained medical 
teams can handle many seriously poisoned patients at once if they 
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know immediately what type of poisoning has occurred. 
People respond amazingly well in stressful conditions that 
have not been experienced before if they have good leadership and 
have given consideration to a proposed plan of action. All terrify-
ing situations panic people and reduce judgment. It is easy to 
understand that a plan is needed to get work properly directed and 
organized. Leadership must be assumed at all levels. Leadership 
is most effective when key command personnel understand the situa-
tion and know what needs to be done. 
Determining the seriousness of anticholinesterase poisoning 
of a given individual in a mass casualty situation is complicated by 
lack of time and an over burdened laboratory. Eye signs are re-
putedly no good. Serum anticholinesterase levels can't be run on 
hundreds to thousands in time to be effective. 
Cyanosis, respiratory arrest, coma, convulsions or flaccid 
para~sis are definite signs of serious poisoning and demand that 
vigorous and immediate treatment be given. 
All patients should enter only one entrance and quickly be 
screened. It is very important to quickly designate and limit the 
contaminated area. A certain number of Doctors, Nurses and other 
medical personnel will be casualties due to initial attack, placing 
an added burden on those remaining. The remaining staff must take 
immediate steps to protect themselves from contamination from the 
patients. The screening station personnel should be protected with 
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gas masks, chemically impregnated or rubber impermeable suits and 
rubber gloves. 
Assuming that all patients are nerve gas casualtiesconly, 
which greatly reduces the screening problems, the following system 
may be used. The first screen by a doctor taking only seconds per 
patient could separate the critically poisoned patients using the 
signs stated above as critera, from the lesser poisoned ones. The 
patients showing signs of poisoning but still capable of walking and 
breathing unassisted at the moment at least, could form a line where 
several nurses could quickly administer I.V. atropine or 2-PAM if 
necessary. This procedure hopefully taking only seconds per patient 
if the nurses are constantly resupplied so tbe,y do nothing but ad-
minister atropine. The use of signs or of one individual leading 
a group of ten to twenty people could lead these patients to an 
area where they could remove all their clothing. The men could be 
separated from the women if facilities permit. These people could 
be led to showers where they decontaminate themselves with soap and 
wa ter, taking extra care to thoroughly wash the hair a nd fingernails. 
Again one person could supervise the shower to supply soap, give 
instructions and keep the patients moving. The patient being de-
contaminated could be given clothing and moved into another part of 
the medical aid station that is not contaminated. The g.coup could 
then use the "buddy system" to observe on another and report any 
difficulty in breathing. A smaller medical team could then treat 
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this large group because hopefully they aren't as seriously poisoned 
and maybe only I.V. atropine is necessary. If they become seriously 
poisoned they should be transferred to maximum care section imme-
diately where personnel and. equipment is available. 
Returning to the first screening station let us follow the 
handling of a seriously poisoned patient. These patients should be 
separated from the less serious patients and be di. rected toward in-
tensive care. The next station and very close by, should have a 
doctor and nurse acting as a team. The doctor can insert an endo-
tracheal tube quickly, suction out the respiratory tract and evaluate 
the patient further. The nurse would immediat ely gi V'e 1. V. atropine 
and 2-PAM. It must be remembered that atropine cannot be given 
while cyanosis is present. The patient should then be quickly 
moved to a permanent high intensive care station freeing the second 
station to take care of another patient. 
The third station is also an intermediate station being set up 
to administer drugs, 02' and suction. All personnel should be pro-
tected against contamination. The purpose of this station is to 
decontaminate the patient and still maintain him. This station 
needs to be staffed by many more personnel so decontamination can 
be done quickly to a patient Who cannot help himself. 
The fourth station, the uncontaminated high intensive care 
area, should be arranged in groups of four. The patients could be 
arranged in a small square with their heads together. A centrally 
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located suction machine could then be used to keep the airways open 
without moving the machine muCt'1. Large mass casualty situations 
may require expanding the number to more than four. One person 
could keep a number of airways open using this technique. A cer-
tain amount of sterile technique would have to be overlooked as a 
sterile tube could not be placed down each individual as the suction 
machine is being used. When the time and situation permits anti-
b~tics could be given, if needed, to treat resultant respiratory 
infection. 
The time element as in all poisonings is very important but 
this problem compounds the seriousness of the disaster if thousands, 
if not hundreds of thousands are affected at the same time. Ex-
posed people need help immediately and w~y not get to medical aid 
stations in tLme. Existing rescue services is not the answer. 
They would either be quickly swamped with work and could not get 
to aid all needing help or the rescue teams themselves might be 
poisoned. 
Equipment and drug requirements may be another source of 
failure to adequately handle mass casualties. Most 2~ bed hospi-
tals probably have less than ten artificial respirators. Endo-
tracheal tubes are probably more abundant but would fall short of 
hundreds that may be needed all at once. 
According to Dr. Charles W. Steele, speaking before the ninth 
ar~ual U. S. Civil Defense Counsel Conference at Minneapolis in 
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September, 1960, tlif all the atropine available to civilian defense 
authorities were distributed among physicians, each physician would 
have about 6 doses or less than the amount needed for one severe 
case of poisoning." 
Robert A. Lehaan, the Vice President and Research Director of 
Campbell Pharmaceuticals, Inc., 121 East 24th Street, New York 10, 
New York, states the 2-PAM (Protopam Chloride) will be available 
for general distribution by his company around January 1964. Pre-
sently this drug is available on a research basj~ only. 
The drug shortage is evident, however. Stockpiling the drug 
might not solve the problem as the time necessary to distribute 
the drug from supply areas might for all practical purposes nullify 
the usefulness of t he drug. 
Today the most basic protection against the nerve gases is to 
have good military intelligence to warn of imminent attack and com-
pletely evacuate the area. 
Presently 2-PAM chloride is being considered for use as a 
prophylactic agent to protect against nerve gases. Studies aren't 
complete on its prophylactic use. The success of 2-PAM as a definite 
therapeutic agent in poisoned eases leaves hope that it may also 
be used as a pre-exposure protecting agent. 
SUMMARY 
The cholinesterase inhibiting agents considered here are or-
ganic phosphorus compounds which irreversibly bind the enzyme 
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cholinesterase. This action blocks the hydrolysis of acetylcholine 
and acetylcholine is allowed to accumulate. Excessive acetylcholine 
at the myoneural junction decreases its function and can lead to 
flaccid paralysis. The accumulated acetylcholine also over stimu-
lates the parasympathetic nervous system causing excessive secre-
tions by the glands they innervate. This type poisoning manifests 
muscarine-like and nicotine-like effects. The muscarine-like ef-
fects include nausea, vomiting, diarrhea, excessive salivation, 
sweating and dyspnea. The nicotinic-like effects are muscular 
weakness, fasiculations, cramps and finally paralysis. The mech-
anism of death is due to respiratory failure. Treatment involves 
maintaining respiration and directing medical attention towards 
breaking down the cholinesterase block which is irreversible with-
out drug intervention. Oximes such as 2-PAM (2-pyridine-aldoxime-
methochloride) are specific in action of reactivating the enzyme 
cholinesterase and reacting chemically with the anticholinesterase 
agent. Atropine therapy is also specific for symptomatic contr~ 
of excessive glandular secretion caused by the accumulated acetyl-
choline. 
Common sources of anticholinesterase poisoning are from insec-
ticides such as parathion, matathion, chlorthion, phorate and other 
organic phosphorus compounds. The military war gases, the "nerve 
gases", such as sarin (isopropylmethylphosponofluoridate) are very 
potent anticholinesterase agents. The treatment is the same for 
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all the above agents. 
Treatment of a severe case of anticholinesterase poisoning with 
coma, cyanosis or respiratory distress present. 
1. Maintain Airway 
A.Endotracheal intubation. 
B. Suction airway. 
2. Artificial respiration 
A. Use a positive pressure method of artificial respiration 
because of possible respiratory muscle para~sis and a 
restricted airway. 
B. If a mechanical respirator is not used, then watch patient 
very closelY for sudden respiratory arrest. 
C. Cyanosis must be corrected before atropine can be admin-
istered otherwise there is great possibility of inducing 
ventricular fibrillation. 
3. Atropine Administration 
A. Adults: 
1. Give 2 to 4 mg atropine intravenously. 
2. Repeat dosage at 5 to 10 minute intervals until signs 
of atropinization appear. 
3. A mild degree of atropinization should be maintained 
for 48 hours. (Dry, flushed skin, tachycardia.) 
B. Children 
1. 1 mg per square meter surface area. 
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4. 2-PAM Chloride therapy (2-Pyridine-Aldoxime-Methochloride). 
A. Adults. 
1. 1000 mg 2-PAM intravenously at a rate not to exceed 
500 mg per minute. 
2. The above dose may be repeated in one hour if muscle 
weakness has not been relieved. Additional doses may 
be given if muscular weakness persists, however, caution 
must be used because 2-PAM is a weak anticholinesterase 
agent itself. 
3. 2-PAM can be given orally, intramuscularly, or sub-
cutaneously if intravenous method is not feasible. 
B. Children. 
1. The dosage of 2-PAM is 25 to 50 mg per kg. 
C. 2-PAM may be obtained from Campbell Pharmaceuticals, Inc., 
121 East 24th Street, New York 10, New York. 
5. Decontaminate Patient. 
A. Medical personnel should protect themselves against con-
tamination by wearing rubber gloves. 
B. Remove patients clothing and wash skin with soap and water. 
C. Then wash with alcohol sL~ce many anticholinesterase are 
more soluble in alcohol than in water. 
D. Wash eyes with physiologic saline or tap water. 
E. If ingestion has occurred induce a~esis or give gastric 
lavage with 5% sodium bicarbonate. 
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6. Convulsions. 
A. If conwlsions occur treat with one gram Trimethadione 
(Tridione) intravenously every 15 minutes until controlled. 
Barbituates or ether may be used with caution. 
7. Contraindicated Drugs. 
A. Morphine, theophylline, aminophylline, succinylcholine 
and phenothiazine derived tranquilizers are contraindi-
cated. 
B. Smoking should be forbidden as this increases respiratory 
and gastrointestinal symptoms. 
8. Observe Patient. 
A. The patient should be observed for at least 24 hours after 
symptoms have subsided because fatal relapses can occur 
due to continuing absorption of the poison or the dissi-
pation of the effect of the antidote. 
9. J/rlld Cases of Poisoning. 
A. Mild cases demonstrating only headaches, blurred vision 
and mild rr~scarinic signs can be treated by decontaminating 
the patient and giving 1000 to 2000 mg 2-PAM chloride 
orally in a single dose. This treatment usually gives 
full renussion of symptoms in one hour. The patient must 
be kept under medical supervision for at least 24 hours. 
If 2-PAM is not available, mild cases can often be con-




is specific for reversing the choli.nesterase inhibitor 
and that atropine can only block the parasympathetic 
activity. 
CONCLUSI0r! 
The anticholinesterases are the basis of many insecticides 
and of nerve gas warfare. The potential and hazards of these a-
gents are not well known. Severe poisoning by either agent CQuld 
cause death in minutes. Nerve gas has the potential to kill 80% 
of the population in a several thousand square mile area. The 
seriousness can be compared to the well heralded atomic warfare 
potential that can destroy 50% of the population over a few hundred 
square mile area. Much education, planning and preparation for 
protection against atomic war by the public has occurred in the 
past 15 years. Very little has been said about nerve warfare. 
This author feels that many physicians don't understand the 
problems in the treatment of anticholinesterase poisonings. This 
lack of knowledge may cause the delay in treatment while the Doc-
tor is getting this information. The delay mlly lead to death in 
a seriously poisoned patient. 
Mass casualty poisonings such as those that could occur vdth 
use of the "nerve gases lt could find the nation unprepared medically. 
The increased use of insecticides may present more poisonings by 
these agents in the future. The drugs necessary of specific treat-
ment aren't generally present in most centers in either type or 
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amount. 2-PAM is available only for research use. Atropine, a 
common drug, is normally used in very small quanti ties. How many 
hos pi tals or clinics could supply the amount of atropine necessary 
to treat several patients requiring 40 mg a day for each patient? 
Immediate lack of mechanical respirators, endotracheal tubes and 
protective clothing adds to the medical state of unpreparedness to 
prevent mass homocide in nerve gas warfare. 
The only sound solution to this problem is to develop a pro-
phylactic drug protecting against anticholinesterase poisoning and 
the production and distribution of the drug making it available 
for immediate use. 2-PAM appears to have the most promise to meet 
these demands but a more active research program and national con-
cern of this problem is necessary. A prophylactic drug could lend 
itself to a national program s~~r to that carried out with the 
oral polio vaccines. The drug could be distributed to the popu-
lation so that it would be ready for immediate use in the event 
of imminent exposure. A smaller scale program could prevent in-
dustrial poisonings to labors working with insecticides. 
-
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